{"changeSha256":"80c6e2802417c72881f27d3757c7869c283dab8d35b47bdd053013d8d89f277c","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Linzess","before":"U.S. label record","field":"Status"},{"after":"A guanylate cyclase-C agonist approved by FDA as Linzess for irritable bowel syndrome with constipation and chronic constipation in adults, and for certain uses in children.","before":"A guanylate cyclase-C agonist peptide. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"Large randomized, placebo-controlled trials described in the label support its adult uses. The label carries a boxed warning: it is contraindicated in children younger than 2 because of a risk of serious dehydration.","before":"The cited DailyMed label identifies Linaclotide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39, fda-drugs-nda202811-2012-08-30-4be8911e4fc0, fda-drugs-anda209564-2021-02-09-c16b14d7f4e0, fda-drugs-anda209611-2023-02-07-1f1bc2997a49","before":"dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39]; U.S. Food and Drug Administration [sources: fda-drugs-nda202811-2012-08-30-4be8911e4fc0]","before":"U.S. National Library of Medicine [sources: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39]","field":"Named organizations"},{"after":"name: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; aliases: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; category: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; status: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39, fda-drugs-nda202811-2012-08-30-4be8911e4fc0; summary: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39, fda-drugs-nda202811-2012-08-30-4be8911e4fc0; evidenceNote: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39","before":"name: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; aliases: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; category: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; status: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; summary: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39; evidenceNote: dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/linaclotide/versions/3/","version":3},"id":"profile:linaclotide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the Linzess label, and added Drugs@FDA approval records for Linzess and generic linaclotide.","peptideSlugs":["linaclotide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/linaclotide/v2.json","sha256":"6bd84f42203676fd09328eabd47a84df801294c0eb952801c67c0b7dba434b48"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/linaclotide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"LINZESS (linaclotide) capsule · SPL version 39 · published 2026-06-01","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=39","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda202811-2012-08-30-4be8911e4fc0","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA202811 · original submission status AP · 2012-08-30 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA202811%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"linaclotide","type":"profile"}}
